From BJBMS to Biomolecules and Biomedicine: A new chapter

Faruk Skenderi; Lamija Mlaco; Muzafer Mujic; Semir Vranic

doi:10.17305/bb.2025.12867

Authors

Faruk Skenderi Biomolecules and Biomedicine, Sarajevo, Bosnia and Herzegovina https://orcid.org/0000-0002-2200-354X
Lamija Mlaco Biomolecules and Biomedicine, Sarajevo, Bosnia and Herzegovina https://orcid.org/0009-0007-2813-9740
Muzafer Mujic Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina, Sarajevo, Bosnia and Herzegovina
Semir Vranic College of Medicine, QU Health, Qatar University, Doha, Qatar

DOI:

https://doi.org/10.17305/bb.2025.12867

Keywords:

Biomolecules and Biomedicine, Impact factor, CiteScore

Abstract

The scientific community is continually evolving, driven by advancements, shifting priorities, and growing demands for global dissemination of knowledge. A clear example of successfully adapting to these demands is the transition from the Bosnian Journal of Basic Medical Sciences (BJBMS) to Biomolecules and Biomedicine (BB) in 2023. This strategic move symbolizes a significant step forward, expanding the journal’s global reach and scientific scope.